For example, there is a new study, IMPACT (The Identification of Men with genetic predisposition to ProstAte Cancer: Targeted screening in BRCA1/2 mutation carriers), and our study has informed the way that these men are invited into the study. The gene discussed is BRCA1; the disease is prostate cancer.